In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Practice Guideline Track on Management of Dyslipidaemias

Guidelines Into Practice

Coronary Artery Disease (Chronic)
Cardiovascular Disease in Primary Care
Rehabilitation and Sports Cardiology
Basic Science
Cardiovascular Rehabilitation
Risk Factors and Prevention
Cardiovascular Pharmacotherapy

Contributors:  Special thanks to Professor Olov Wiklund and Professor Guy De Backer 

Based on the 2016 ESC Guidelines on Dyslipidaemias 2016 (Management of)

Webinars on this topic

 2016 ESC webinar on "ESC Guidelines on Dyslipidaemias 2016: new knowledge and tools for lipid management"  streamed live on 4 Oct 2016: Watch the recording.

Part 1 - Overview of the Guidelines

Session title Slides Webcast
Dyslipidaemias part 1    
Dyslipidaemias part 2    
LDL lowering: the evidence    
The new lipid guidelines    
Other lipoproteins do they matter?    
Future challenges    
ESC Clinical practice guidelines 2016. Highlights - Dyslipidaemias    

Part 2 - Topics in focus

Topic/Section Session title Slides Webcast
Prevention and Rehabilitation LDL vs non-HDL cholesterol.Where do we stand?    
Prevention and Rehabilitation New emerging therapies    
Prevention and Rehabilitation Goals, percent reduction or both?    
Prevention and Rehabilitation Familial hypercholesterolaemia, underdiagnosed and undertreated condition    
Prevention and Rehabilitation Utility of apoB target over LDL-C and non-HDL-C targets: insights from the national health and nutrition examination survey    
Prevention and Rehabilitation Familial hypercholesterolaemia diagnosis: a case of missed opportunity    
Prevention and Rehabilitation A naturally randomised trial comparing the effect of long-term exposure to lower LDL-C, lower SBP or both on the risk of cardiovascular disease    
Basic Science Low levels of LDL-cholesterol and incidence of a wide range of cardiovascular disease: a linked electronic health records cohort of 550 000 people    
Acute Coronary Syndrome The benefit of adding ezetimibe to statin therapy in patients with and without prior coronary artery bypass graft surgery in the IMPROVE_IT trial    
Prevention and Rehabilitation Current evidence and best practice for lipid management in young adults. State of the art    
Interventional Cardiology and Surgery Advances in the treatment of dyslipidaemias    
Prevention and Rehabilitation Decline over the years in the risk of cardiovascular events in patients with the clinically manifest vascular disease is explained by a change in CV risk factors and atherosclerotic burden    
Prevention and Rehabilitation Do we need to worry about HDL?